Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2315875Aexternal-prioritypatent/JPS5837316B2/ja
Priority claimed from JP3375975Aexternal-prioritypatent/JPS5951553B2/ja
Priority claimed from JP3471475Aexternal-prioritypatent/JPS5951554B2/ja
Priority claimed from JP127476Aexternal-prioritypatent/JPS5283869A/ja
Application filed by Takeda Chemical Industries LtdfiledCriticalTakeda Chemical Industries Ltd
Priority to CA352,064ApriorityCriticalpatent/CA1103236A/fr
Application grantedgrantedCritical
Publication of CA1103236ApublicationCriticalpatent/CA1103236A/fr
Acides 2-(2-aminothiazol-4-y1)-n-(imidazolidin-2- on-1-yl)-2-imino-acetylaminocephalosporaniques sous forme d'isomere syn; methode pour les preparer, et acide syn utilise dans cette methode